MARKET

RKTO

RKTO

ROCKET ONE INC
NASDAQ
0.5999
-0.0494
-7.61%
Pre Market: 0.6181 +0.0182 +3.03% 05:10 10/13 EDT
OPEN
0.6502
PREV CLOSE
0.6493
HIGH
0.6510
LOW
0.5949
VOLUME
13.41K
TURNOVER
0
52 WEEK HIGH
2.450
52 WEEK LOW
0.4894
MARKET CAP
14.94M
P/E (TTM)
-0.7255
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RKTO last week (1005-1009)?
Weekly Report · 1d ago
Rocket One signs patent anti-drone tech license agreement with U.S. Air Force
TipRanks · 6d ago
Rocket One Inks Patent License Deal With Department Of Air Force For Its Technology Designed To Capture Hostile Drones And Isolate Their Communications
Benzinga · 6d ago
Weekly Report: what happened at RKTO last week (0928-1002)?
Weekly Report · 10/05 09:24
Weekly Report: what happened at RKTO last week (0921-0925)?
Weekly Report · 09/28 09:22
Rocket One Sets Date for 2026 Annual Meeting
TipRanks · 09/25 21:07
Rocket One to acquire Tracer Drone Technologies
TipRanks · 09/22 12:15
Rocket One Agrees To Acquire Tracer Drone Technologies; Financial Terms Not Disclosed
Benzinga · 09/22 12:13
More
About RKTO
Rocket One Inc. is an artificial intelligence (AI) semiconductor infrastructure company. The Company is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic artificial intelligence (AI) chip technology designed for radiation-tolerant, energy-constrained environments such as low-earth orbit, deep-space platforms, and defense systems. It operates through two segments, which include Biopharmaceutical and AI semiconductor infrastructure. It is also focused on a nanomagnetic matrix multiplier, Skyrmion Spintronic memory, and Swarm Stage AI. The Company's biotechnology pipeline includes HT-001, HT-KIT, HT-ALZ, and its glial cell line derived neurotrophic factor (GDNF)-based metabolic program. The HT-001 is used to treat epidermal growth factor receptor (EGFR)-induced skin disorders. The HT-KIT drug is used to treat the receptor tyrosine kinase KIT in mast cells.

Webull offers Rocket One Inc stock information, including NASDAQ: RKTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RKTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RKTO stock methods without spending real money on the virtual paper trading platform.